| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/21/2001 | WO2001043540A2 Methods for producing transgenic animals |
| 06/21/2001 | WO2001017955A3 Hydroxyacetamidobenzenesulphonamide derivatives |
| 06/21/2001 | WO2001016136A3 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 06/21/2001 | WO2001010851B1 Process for the preparation of lysine-carboxyanhydride intermediates in the synthesis of lisinopril |
| 06/21/2001 | WO2001010411A3 Implantable active ingredient depot |
| 06/21/2001 | WO2000078972A8 Regulation with binding cassette transporter protein abc1 |
| 06/21/2001 | WO2000071103A3 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 06/21/2001 | WO2000061568A8 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 06/21/2001 | US20010004643 Pharmaceutical composition with sotalol combination and their use in treatment of cardiac ailments |
| 06/21/2001 | US20010004639 Process for preparing arylacetylaminothiazoles |
| 06/21/2001 | DE19957318A1 Beeinflussung von TGF-Beta durch Proteolytische Enzyme Influence of TGF-beta by proteolytic enzymes |
| 06/21/2001 | CA2551203A1 Novel forms of pravastatin sodium |
| 06/21/2001 | CA2396543A1 Conjugated fatty acids and related compounds, and method for their enzymatic preparation |
| 06/21/2001 | CA2395585A1 Chimeric natriuretic peptides |
| 06/21/2001 | CA2395486A1 Saccharin derivatives as orally active elastase inhibitors |
| 06/21/2001 | CA2395474A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 06/21/2001 | CA2395289A1 Transdermal administration of phenylpropanolamine |
| 06/21/2001 | CA2395088A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 06/21/2001 | CA2394613A1 Method for localized administration of fibrinolytic metalloproteinases |
| 06/21/2001 | CA2394600A1 Methods for producing transgenic animals |
| 06/21/2001 | CA2394570A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 06/21/2001 | CA2394538A1 Aminothiazole inhibitors of cyclin dependent kinases |
| 06/21/2001 | CA2394536A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | CA2394504A1 Fragments and antagonists of heat shock protein 60 |
| 06/21/2001 | CA2394466A1 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | CA2394431A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 06/21/2001 | CA2394420A1 Novel polypeptide and dna thereof |
| 06/21/2001 | CA2394167A1 Compositions and methods for inhibiting endothelial cell proliferation |
| 06/21/2001 | CA2394130A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
| 06/21/2001 | CA2394077A1 System and method for extended delivery of a therapeutic agent with its receptor loading dose |
| 06/21/2001 | CA2393972A1 Cyclopenteneone derivatives |
| 06/21/2001 | CA2393762A1 Hydroxide-releasing agents as skin permeation enhancers |
| 06/21/2001 | CA2393672A1 Selective neurokinin antagonists |
| 06/21/2001 | CA2393292A1 Brain specific binding members |
| 06/21/2001 | CA2392992A1 Imidazopyrimidinyl and imidazopyridinyl derivatives |
| 06/21/2001 | CA2392894A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 06/21/2001 | CA2392766A1 Novel helicobacter pylori-binding substances and use thereof |
| 06/20/2001 | EP1108436A1 Preventives/remedies for arteriosclerosis and post-ptca reangiostenosis |
| 06/20/2001 | EP1108424A1 Matrix tablet for sustained release of trimetazidine after oral administration |
| 06/20/2001 | EP1108051A2 Inducible expression system |
| 06/20/2001 | EP1108047A1 Targeted adenovirus vectors for delivery of heterologous genes |
| 06/20/2001 | EP1108039A2 Elongase genes and uses thereof |
| 06/20/2001 | EP1108029A1 Kunitz domain polypeptide zkun6 |
| 06/20/2001 | EP1107996A1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES |
| 06/20/2001 | EP1107973A1 Novel compounds |
| 06/20/2001 | EP1107971A1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them |
| 06/20/2001 | EP1107968A2 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one |
| 06/20/2001 | EP1107963A1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 06/20/2001 | EP1107962A1 Quinolin-2-one derivatives useful as anticancer agents |
| 06/20/2001 | EP1107959A2 Quinazoline derivatives as medicaments |
| 06/20/2001 | EP1107957A1 Pyrimidine compounds |
| 06/20/2001 | EP1107954A1 2-OXO-$i(2H)-QUINOLINE DERIVATIVES |
| 06/20/2001 | EP1107953A1 Hydroxamic acid derivatives as proteinase inhibitors |
| 06/20/2001 | EP1107797A2 Hypoxia regulated genes |
| 06/20/2001 | EP1107795A2 Methods and compositions for the prevention or treatment of cancer |
| 06/20/2001 | EP1107791A2 Hydrogel compositions for the controlled release administration of growth factors |
| 06/20/2001 | EP1107790A1 Targeting of molecules to large vessel endothelium using epcr |
| 06/20/2001 | EP1107788A1 Scrp-5: secreted cysteine rich protein-5 |
| 06/20/2001 | EP1107780A2 Selective treatment of endothelial somatostatin receptors |
| 06/20/2001 | EP1107778A1 Treatment of disease states |
| 06/20/2001 | EP1107775A1 Composition containing pyrrolizidine-alkaloid-free petasites |
| 06/20/2001 | EP1107774A1 Ramp2a: receptor activity modifying protein-2a |
| 06/20/2001 | EP1107768A1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE |
| 06/20/2001 | EP1107765A2 3-deazaadenosine prevents atherosclerosis and graft vasculopathy |
| 06/20/2001 | EP1107762A1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure sexual dysfunction in women |
| 06/20/2001 | EP1107758A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| 06/20/2001 | EP1107755A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 06/20/2001 | EP1107752A1 Pyrrolidine derivatives for vision and memory disorders |
| 06/20/2001 | EP1107741A1 Orally administered controlled drug delivery system providing temporal and spatial control |
| 06/20/2001 | EP1107738A1 Novel pharmaceutical salt form |
| 06/20/2001 | EP1107737A1 Microparticles |
| 06/20/2001 | EP1107733A1 Oral liquid mucoadhesive compositions |
| 06/20/2001 | EP1107722A2 A method for the treatment of staphylococcal disease |
| 06/20/2001 | EP1107702A1 Ultrasonic enhancement of drug injection |
| 06/20/2001 | EP1071485A4 Revascularization apparatus having coaxial channeling and injection means |
| 06/20/2001 | EP0934301B1 Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors |
| 06/20/2001 | EP0929515B1 Novel phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same |
| 06/20/2001 | EP0920438B1 N6 heterocyclic substituted adenosine derivatives |
| 06/20/2001 | EP0889875B1 Cyclopropyl alkanoic acid derivatives |
| 06/20/2001 | EP0796260B1 Rapamycin 42-oximes and hydroxylamines |
| 06/20/2001 | CN1300303A Enzyme inhibitors |
| 06/20/2001 | CN1300285A Oxyiminoalkanoic acid derivatives |
| 06/20/2001 | CN1300282A Pyrazole derivatives as P-38 MAP kinase inhibitors |
| 06/20/2001 | CN1300280A Process for the preparation of (R)-& alpha, -(2,3-dimethoxyp-henyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 06/20/2001 | CN1300278A Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 06/20/2001 | CN1300277A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 06/20/2001 | CN1300221A Treatment of cardiao hypertrophy |
| 06/20/2001 | CN1300220A Peptide compositions and formulations and use of same |
| 06/20/2001 | CN1300218A Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 06/20/2001 | CN1300214A Composition comprising acarnitine and glutathione, useful to incrense the absorption of glutathione and synergize its effects |
| 06/20/2001 | CN1300212A Novel fatty analogues for the treatment of obesity, hypertension and fatty liver |
| 06/20/2001 | CN1300211A Novel fatty analogues for the treatment of premary and secondary restenosis |
| 06/20/2001 | CN1299813A N-substituted benzyl or phenyl aromatic amide compound and its use |
| 06/20/2001 | CN1299679A Arthralgia treating prescription |
| 06/20/2001 | CN1299672A Preparation of hemiplegia treating capsule |
| 06/20/2001 | CN1299653A Naomaisu medicine |
| 06/20/2001 | CN1067393C Novel pyrimido [1,2-alpha] indoles |
| 06/20/2001 | CN1067391C Piperidyl methyl oxazolidinone |
| 06/20/2001 | CN1067384C Adhesion receptor antagonists, its preparation method and use as farm chemicals |